TROUGH INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES IN SPONDYLOARTHRITIS PATIENTS ON TREATMENT WITH LOW DOSE INFLIXIMAB: A SINGLE CENTRE CROSS-SECTIONAL STUDY

被引：0
|
作者：
Patil, A. [1 ]
Upadhyaya, S. K. [1 ]
Dawar, R. [2 ]
Vaishnav, B. [1 ]
Dadhaniya, N. [1 ]
Gupta, S. J. [1 ]
Handa, R. [1 ]
机构：
[1] Indraprastha Apollo Hosp, Rheumatol, Delhi, India
[2] Indraprastha Apollo Hosp, Microbiol, Delhi, India
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.2690
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0683
引用
收藏
页码：1292 / 1292
页数：1
相关论文
共 50 条
  • [1] Commentary: detection of infliximab levels and anti-infliximab antibodies
    Seow, C. H.
    Panaccione, R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (01) : 153 - 154
  • [2] Serum trough infliximab and anti-infliximab antibodies in a cohort of gastroenterology and rheumatology patients' infliximab therapeutic drug monitoring
    Barlow, Nicola L.
    Mohammed, Pervaz
    Berg, Jonathan D.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2016, 53 (04) : 477 - 484
  • [3] Significance of low level infliximab in the absence of anti-infliximab antibodies
    Bella Ungar
    Adi Anafy
    Henit Yanai
    Yulia Ron
    Miri Yavzori
    Orit Picard
    Ella Fudim
    Ronen Loebstein
    Uri Kopylov
    Yehuda Chowers
    Iris Dotan
    Rami Eliakim
    Shomron Ben-Horin
    World Journal of Gastroenterology, 2015, (06) : 1907 - 1914
  • [4] Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
    van der Maas, Aatke
    van den Bemt, Bart J. F.
    Wolbink, Gertjan
    van den Hoogen, Frank H. J.
    van Riel, Piet L. C. M.
    den Broeder, Alfons A.
    BMC MUSCULOSKELETAL DISORDERS, 2012, 13
  • [5] Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
    Aatke van der Maas
    Bart JF van den Bemt
    Gertjan Wolbink
    Frank HJ van den Hoogen
    Piet LCM van Riel
    Alfons A den Broeder
    BMC Musculoskeletal Disorders, 13
  • [6] Anti-infliximab antibodies in RA patients treated with infliximab.
    Wolbink, GJ
    Lems, WF
    Nurmohamed, MT
    Vis, M
    Voskuyl, AE
    Stapel, S
    de Groot, E
    Tak, PP
    Dijkmans, BA
    Aarden, L
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S187 - S187
  • [7] LOW INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES INCREASE THE RISK OF LOSS OF RESPONSE TO INFLIXIMAB IN PEDIATRIC IBD, A PROSPECTIVE PEDIATRIC STUDY
    Zitomersky, Naamah
    Chi, Lisa
    Liu, Enju
    Tollefson, Sophia
    Stern, Julia Bender
    Naik, Snehal
    Rufo, Paul A.
    Snapper, Scott B.
    Bousvaros, Athos
    GASTROENTEROLOGY, 2018, 154 (06) : S60 - S60
  • [8] Anti-drug antibodies and low serum trough infliximab levels correlate with disease activity measures in spondyloarthritis patients on an as-needed infliximab treatment
    Patil, Abhishek
    Upadhyaya, Sundeep
    Dawar, Reetika
    Dadhaniya, Nikunjkumar
    Sood, Isha
    Gupta, Sirinder J.
    Handa, Rohini
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (09) : 1638 - 1643
  • [9] Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease
    Steenholdt, Casper
    Bendtzen, Klaus
    Brynskov, Jorn
    Thomsen, Ole Ostergaard
    Ainsworth, Mark Andrew
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2011, 46 (03) : 310 - 318
  • [10] Loss of Response in IBD Patients on Infliximab Treatment: Assay of Infliximab Trough Levels and Total Antibodies to Infliximab
    Guidi, Luisa
    Marzo, Manuela
    Pugliese, Daniela
    Felice, Carla
    Andrisani, Gianluca
    Papa, Alfredo
    Rapaccini, Gian Ludovico
    Armuzzi, Alessandro
    GASTROENTEROLOGY, 2015, 148 (04) : S857 - S857
12345